The significance of serum leptin level in patients with early stage nonsmall cell lung cancer


Karatas F., YALÇIN B., Sahin S., AKBULUT H., Utkan G., DEMİRKAZIK A., ...More

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, vol.13, no.2, pp.204-207, 2017 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 13 Issue: 2
  • Publication Date: 2017
  • Doi Number: 10.4103/0973-1482.196859
  • Title of Journal : JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
  • Page Numbers: pp.204-207

Abstract

Backgrounds: The serum leptin level (SLL) has been shown to increase in patients with nonsmall cell lung cancer (NSCLC). However, available data regarding the relation between SLL and tumor subtypes, survival, cachexia, and tumor respectability in NSCLC are still under debate. The aim of this study is to evaluate SLL in NSCLC patients with and without cachexia.